TN govt to set up comprehensive pharma park with separate units for formulations, devices and APIs soon
The Government of Tamil Nadu will soon announce its landmark decision to set up a comprehensive pharma park with three units each for formulations, APIs and medical devices. This was announced by J Jeyaseelan, chairman of TN IDMA at the inaugural session of the fifth Pharmac South Expo at Chennai Trade Centre on June 28.
The government is holding discussions with the industry and other stakeholders and an announcement from government side is expecting in another six months, he informed the participants at the meeting.
Another promotional impetus to the manufacturers of pharmaceuticals is that the government will increase the 10 per cent price preference currently giving to the manufacturers through Tamil Nadu Medical Services Corporation. Jayaseelan was delivering the welcome address at the inaugural function.
While sharing an overview of Pharmac South with the audience, S V Veeramani, former president of IDMA, said the pharma park is likely to be set up in Gummidipundi, near Chennai and it will be very much helpful for all the pharma industrial units in Tamil Nadu. He said the government of India is supporting the pharma sector in a big way and now the government has decided to increase the total outlay for health to 2.5 per cent from the existing 1 per cent. He said the Indian pharma industry is growing at a rate of 10 per cent, while in the global level, pharma industry is growing at 5 per cent only.
Dr T V Narayana, president of Indian Pharmaceutical Association (IPA), while addressing the entrepreneurs said Indian pharmaceutical sector is blessed with qualified professionals. There are over 1.5 million registered pharmacists, eight lakh community pharmacies, 60,000 pharmacy teachers, 3,000 pharmacy colleges and 10,900 drug regulatory officers including 560 from the central government, CDSCO. When compared to other countries, this quantum of brains is a big achievement. IPA covers all their associations and take up their issues with the concerned authorities.
Seeking cooperation of industry associations, especially of IDMA, the deputy director of the CDSCO in Chennai, Shanty Gunashekharan said the central regulatory department is becoming more flexible in enforcing drug laws in the wake of Ease of Doing Business, and as a result the industry needs to conduct self-regulation in their own units. But the department has no compromise on its part in implementing the laws. “For grant of new license joint inspections have been established, online filing of all applications through Sugam portal was introduced, Medical Devices Rules 2017 and New Drugs and Clinical Trial Rules have been introduced. All these are for enforcing the drugs and cosmetics act and the rules in the proper way,” she said.
S Sivabalan, director of Tamil Nadu drugs control department, said the manufacturers should keep in mind that quality of medicine is not only an aspect insisted by drug act, but it is one of the ethics of social responsibility.
V Uday Bhaskar, director general of the Pharmaceutical Export Promotion Council, said it is high time for the generic drug manufacturers to take shift from their conventional method and find a new strategy for manufacturing generics. The industry needs to focus on biosimilars and newer strategies. Similarly, the industry needs to reduce import dependence on foreign countries, especially on China for APIs. A major portion of all the raw materials that Indian manufacturers use is from foreign countries, he said.
V Sreedharan, convener of the event organising committee thanked the speakers and the participants.